Delivery Order SPE2DB24D6039-SPE2DB24FLEBH

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency. The $10,801.04 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, which is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA). The contract is part of Amerisourcebergen's larger...
The Defense Logistics Agency (DLA) has awarded a $16,978.67 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of CONTRAVE ER 8-90 MG TABLET 120S. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide....
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency. The $11,693.25 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on July 11, 2024 with a completion date of July 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
The Defense Logistics Agency (DLA) awarded a $44,039.19 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of 4,566,088 units of the CONTRAVE ER 8-90 MG TABLET 120S medication. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, that enables the government to efficiently procure a wide range of pharmaceutical and medical supplies to support...
This federal contract award is for the delivery of CONTRAVE ER 8/90MG 120, a prescription pharmaceutical product, to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract has a firm fixed price of $28,603.83 and a completion date of September 4, 2024. It is a delivery order contract with no set-aside designation....
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a prescription pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $12,031.15, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CONTRAVE ER 8-90 mg tablets in quantities of 120 per container. The contract has a ceiling value of $17,368.57 and spans from the award date of September 25, 2024 through the ultimate completion date of September 26, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $21,096.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription pharmaceutical product, with a completion date of May 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has a ceiling value of $8,152.21 and an ultimate completion date of May 30, 2024. It is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $10,425.58 and is a firm fixed-price delivery order with an ultimate completion date of September 9, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This contract does not have a set-aside designation....
  • SPE2DB24D6039
    Indefinite Delivery Contract
  • SPE2DB24D6039-SPE2DB24FLEBH
    Delivery Order

This federal contract award is to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA). The $1,590.62 firm-fixed-price delivery order contract has a completion date of September 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which enables the government to efficiently procure a comprehensive range of medical commodities, including prescription drugs and pharmaceuticals, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/24/24, 9:39 AM